Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone.
Leding C, Bodilsen J, Brieghel C, Harboe ZB, Helleberg M, Holm C, Israelsen SB, Jensen J, Jensen TØ, Johansen IS, Johnsen S, Kirk O, Lindegaard B, Meyer CN, Mohey R, Pedersen L, Nielsen H, Nielsen SL, Omland LH, Podlekareva D, Ravn P, Starling J, Storgaard M, Søborg C, Søgaard OS, Tranborg T, Wiese L, Worm SHW, Christensen HR, Benfield T.
Leding C, et al. Among authors: christensen hr.
Infect Dis (Lond). 2023 May;55(5):351-360. doi: 10.1080/23744235.2023.2187081. Epub 2023 Mar 11.
Infect Dis (Lond). 2023.
PMID: 36905638